• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting Histone Lysine Demethylase LSD1/KDM1A as a New Avenue for Cancer Therapy.

作者信息

Fang Yuan, Liao Guochao, Yu Bin

机构信息

Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.

Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou,450018, China.

出版信息

Curr Top Med Chem. 2019;19(11):889-891. doi: 10.2174/156802661911190725094910.

DOI:10.2174/156802661911190725094910
PMID:31389779
Abstract
摘要

相似文献

1
Targeting Histone Lysine Demethylase LSD1/KDM1A as a New Avenue for Cancer Therapy.靶向组蛋白赖氨酸去甲基化酶LSD1/KDM1A作为癌症治疗的新途径。
Curr Top Med Chem. 2019;19(11):889-891. doi: 10.2174/156802661911190725094910.
2
A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.赖氨酸特异性去甲基化酶1及其在癌症中的作用的全面综述。
Epigenomics. 2017 Aug;9(8):1123-1142. doi: 10.2217/epi-2017-0022. Epub 2017 Jul 12.
3
Annual review of LSD1/KDM1A inhibitors in 2020.2020 年 LSD1/KDM1A 抑制剂的年度回顾。
Eur J Med Chem. 2021 Mar 15;214:113254. doi: 10.1016/j.ejmech.2021.113254. Epub 2021 Feb 3.
4
Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment.不可逆 LSD1 抑制剂：反苯环丙胺及其衍生物在癌症治疗中的应用。
Curr Top Med Chem. 2016;16(19):2179-88. doi: 10.2174/1568026616666160216154042.
5
Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1.可逆赖氨酸特异性去甲基化酶 1（LSD1）抑制剂：破坏 LSD1 的有前途的工具。
J Med Chem. 2021 Mar 11;64(5):2466-2488. doi: 10.1021/acs.jmedchem.0c02176. Epub 2021 Feb 23.
6
Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.基于药效团的虚拟筛选结合对接技术鉴定新型选择性赖氨酸特异性去甲基化酶1（LSD1）抑制剂
Chem Biol Drug Des. 2015 Jun;85(6):659-71. doi: 10.1111/cbdd.12461. Epub 2014 Dec 22.
7
Recent Progress in Histone Demethylase Inhibitors.组蛋白去甲基化酶抑制剂的最新进展
J Med Chem. 2016 Feb 25;59(4):1308-29. doi: 10.1021/acs.jmedchem.5b01758. Epub 2016 Feb 2.
8
Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.曲马多酸基赖氨酸特异性脱甲基酶 1 抑制剂：总结与展望。
J Med Chem. 2020 Dec 10;63(23):14197-14215. doi: 10.1021/acs.jmedchem.0c00919. Epub 2020 Sep 30.
9
Epigenetic small molecule modulators of histone and DNA methylation.组蛋白和 DNA 甲基化的表观遗传小分子调节剂。
Curr Opin Chem Biol. 2018 Aug;45:73-85. doi: 10.1016/j.cbpa.2018.03.003. Epub 2018 Mar 24.
10
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.在癌症治疗临床试验中靶向组蛋白甲基转移酶和去甲基酶。
Clin Epigenetics. 2016 May 24;8:57. doi: 10.1186/s13148-016-0223-4. eCollection 2016.

引用本文的文献

1
Mechanistic insights into novel cyano-pyrimidine pendant chalcone derivatives as LSD1 inhibitors by docking, ADMET, MM/GBSA, and molecular dynamics simulation.通过对接、ADMET、MM/GBSA和分子动力学模拟对新型氰基嘧啶侧链查尔酮衍生物作为赖氨酸特异性去甲基化酶1（LSD1）抑制剂的作用机制进行深入研究。
Biochem Biophys Rep. 2025 Feb 12;41:101937. doi: 10.1016/j.bbrep.2025.101937. eCollection 2025 Mar.
2
Pulrodemstat, a selective inhibitor of KDM1A, suppresses head and neck squamous cell carcinoma growth by triggering apoptosis.脯氨酰羟化酶降解酶 1A 选择性抑制剂脯罗德美司他通过诱导细胞凋亡抑制头颈部鳞状细胞癌生长。
BMC Pharmacol Toxicol. 2024 Nov 20;25(1):89. doi: 10.1186/s40360-024-00807-w.
3
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons.
序贯 CRISPR 筛选揭示了部分 NatB 抑制作为减轻人神经元中 alpha-synuclein 水平的策略。
Sci Adv. 2024 Feb 9;10(6):eadj4767. doi: 10.1126/sciadv.adj4767.
4
Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential.HOXA9在实体瘤中的作用：机制洞察与治疗潜力
Cancer Cell Int. 2022 Nov 14;22(1):349. doi: 10.1186/s12935-022-02767-9.
5
Lysine-Specific Demethylase 1 (LSD1/KDM1A) Inhibition as a Target for Disease Modification in Myelofibrosis.赖氨酸特异性去甲基酶 1（LSD1/KDM1A）抑制作为骨髓纤维化疾病修饰的靶点。
Cells. 2022 Jul 3;11(13):2107. doi: 10.3390/cells11132107.
6
Histone demethylase KDM2A: Biological functions and clinical values (Review).组蛋白去甲基化酶KDM2A：生物学功能及临床价值（综述）
Exp Ther Med. 2021 Jul;22(1):723. doi: 10.3892/etm.2021.10155. Epub 2021 May 4.
7
Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors.含1,2,3-三唑部分的5-氰基-6-苯基嘧啶衍生物作为基于黄素腺嘌呤二核苷酸的赖氨酸特异性去甲基化酶1（LSD1）强效抑制剂的研究
Acta Pharm Sin B. 2020 Sep;10(9):1658-1668. doi: 10.1016/j.apsb.2020.02.006. Epub 2020 Feb 24.
8
Discovery of [1,2,3]triazolo[4,5-]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors.发现[1,2,3]三唑并[4,5-]嘧啶衍生物作为高效、选择性且具有细胞活性的USP28抑制剂。
Acta Pharm Sin B. 2020 Aug;10(8):1476-1491. doi: 10.1016/j.apsb.2019.12.008. Epub 2019 Dec 16.
9
Natural products as LSD1 inhibitors for cancer therapy.用于癌症治疗的天然产物作为赖氨酸特异性去甲基化酶1（LSD1）抑制剂
Acta Pharm Sin B. 2020 Jun 20;11(3):621-31. doi: 10.1016/j.apsb.2020.06.007.
10
LSD1/KDM1A inhibitors in clinical trials: advances and prospects.在临床试验中的 LSD1/KDM1A 抑制剂：进展与展望。
J Hematol Oncol. 2019 Dec 4;12(1):129. doi: 10.1186/s13045-019-0811-9.